SP
| |
Select Pharmaceuticals Portfolio | FPHAXMutual Fund | |
Select Pharmaceuticals Portfolio | |
Last update 2025-01-27 | 51 Stocks (1 new) |
Value $1.39 Bil | Turnover 6 % |
Select Pharmaceuticals Portfol... Top Holdings of 2024-11-30
View Full List
Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|
LLY | Eli Lilly and Co | 448,561 | 356,763.0 | -6.03% | 25.720 | -1.50% | 0.050 | -15.77% | -0.42% | 687,521.9 | Drug Manufacturers | |
NVO | Novo Nordisk AS | 2,118,600 | 226,266.5 | +15.56% | 16.310 | +2.20% | 0.050 | -16.34% | -14.90% | 320,101.1 | Drug Manufacturers | |
AZN | AstraZeneca PLC | 1,942,000 | 131,318.0 | 0% | 9.470 | 0% | 0.060 | -5.50% | +13.01% | 225,808.8 | Drug Manufacturers | |
XBRU:UCB | UCB SA | 361,600 | 70,826.1 | -27.97% | 5.110 | -1.37% | 0.190 | -16.44% | -15.20% | 30,682.3 | Biotechnology | |
MRK | Merck & Co Inc | 679,636 | 69,078.2 | -0.22% | 4.980 | -0.01% | 0.030 | -14.71% | -20.64% | 196,538.4 | Drug Manufacturers | |
GSK | GSK PLC | 2,023,560 | 69,064.1 | +3.51% | 4.980 | +0.17% | 0.100 | +7.39% | +23.37% | 82,692.2 | Drug Manufacturers | |
GILD | Gilead Sciences Inc | 628,900 | 58,223.6 | -19.11% | 4.200 | -0.63% | 0.050 | -4.32% | +18.85% | 135,613.2 | Drug Manufacturers | |
LEGN | Legend Biotech Corp | 1,193,000 | 50,189.5 | +43.01% | 3.620 | +1.09% | 0.650 | -10.65% | -6.70% | 5,587.1 | Biotechnology | |
BMY | Bristol-Myers Squibb Co | 585,200 | 34,655.5 | -69.17% | 2.500 | -3.55% | 0.030 | -18.46% | -13.36% | 97,582.1 | Drug Manufacturers | |
ELAN | Elanco Animal Health Inc | 2,275,600 | 30,060.7 | +43.93% | 2.170 | +0.66% | 0.460 | +24.44% | +10.98% | 6,674.9 | Drug Manufacturers |
Select Pharmaceuticals Portfolio's Historical Top Holdings Breakdowns
Select Pharmaceuticals Portfolio's Top Stock Picks
View Full List
Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
---|---|---|---|---|---|---|---|---|---|---|---|
AZN | AstraZeneca PLC | 2024-11-30 | Reduce | -7.84% | 63.2 ($74.24) 85.75 | $73.00 | -1.67% | Reduce -86.23% | 264,317 | -1,655,283 | |
BMY | Bristol-Myers Squibb Co | 2024-11-30 | Reduce | -3.55% | 48.24 ($53.36) 59.82 | $47.95 | -10.14% | Reduce -69.17% | 585,200 | -1,312,700 | |
NVO | Novo Nordisk AS | 2024-11-30 | Add | +2.20% | 99.81 ($117.47) 137 | $72.04 | -38.67% | Add 15.56% | 2,118,600 | 285,200 | |
LLY | Eli Lilly and Co | 2024-11-30 | Reduce | -1.50% | 727.2 ($867.98) 956.53 | $765.84 | -11.77% | Reduce -6.03% | 448,561 | -28,800 | |
XBRU:UCB | UCB SA | 2024-11-30 | Reduce | -1.37% | 158.85 (€171.1) 185.35 | €161.45 | -5.64% | Reduce -27.97% | 361,600 | -140,400 | |
LEGN | Legend Biotech Corp | 2024-11-30 | Add | +1.09% | 37.42 ($45.79) 57.39 | $30.36 | -33.70% | Add 43.01% | 1,193,000 | 358,800 | |
XTER:GXI | Gerresheimer AG | 2024-11-30 | Sold Out | -1.06% | 70.15 (€85.25) 105.3 | €47.78 | -43.95% | Sold Out | 0 | -170,900 | |
DYN | Dyne Therapeutics Inc | 2024-11-30 | Reduce | -1.02% | 28.13 ($32.15) 36.59 | $13.41 | -58.29% | Reduce -44.33% | 515,400 | -410,400 | |
BPMC | Blueprint Medicines Corp | 2024-11-30 | Reduce | -0.89% | 82.47 ($90.37) 101.39 | $128.10 | 41.75% | Reduce -74.76% | 57,900 | -171,500 | |
BIIB | Biogen Inc | 2024-11-30 | Sold Out | -0.85% | 155.43 ($183.08) 204.95 | $131.86 | -27.98% | Sold Out | 0 | -77,100 |
Select Pharmaceuticals Portfolio Total Holding History ($B)
Select Pharmaceuticals Portfolio's Asset Allocation
Select Pharmaceuticals Portfolio Past Portfolios
Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
---|---|---|---|---|
Top Ranked Articles
- 1
Select Pharmaceuticals Portfolio's Hypothetical Growth since 2024-11-30
Select Pharmaceuticals Portfolio's Yearly Returns
Year | Portfolio % | % | Excess Gain % |
---|
Select Pharmaceuticals Portfolio's Holdings Heat Map
Size field:
Select Pharmaceuticals Portfolio's Holdings Bubble Chart
Select Pharmaceuticals Portfolio News
- 1